Overview
Magaldrate is an antacid drug used for the treatment of esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. Magaldrate has been discontinued in the US market.
Indication
用于缓解消化道溃疡、反流性食管炎、急慢性胃炎等酸相关性疾病的症状，如反酸、上腹痛、烧心、腹部不适、嗳气、腹胀等。
Associated Conditions
- Bloating
- Dyspepsia
- Heartburn
- Stress Ulcers
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/08/14 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| MYLANTA 2GO ANTACID DUAL ACTION tablet blister pack | 14378 | Medicine | A | 9/20/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| RIOPAN SUSPENSION 480MG/5ML | wyeth-ayerst canada inc. | 02043580 | Suspension - Oral | 480 MG / 5 ML | 12/31/1994 |
| RIOPAN TAB 480MG | whitehall-robins inc. | 01931059 | Tablet - Oral | 480 MG | 12/31/1993 |
| RIOPAN PLUS TABLETS | whitehall-robins inc. | 01929461 | Tablet - Oral | 480 MG / TAB | 12/31/1993 |
| RIOPAN CHEWABLE TABLETS 480MG | wyeth-ayerst canada inc. | 02043564 | Tablet - Oral | 480 MG | 12/31/1994 |
| RIOPAN PLUS SUSPENSION | whitehall-robins inc. | 01929410 | Suspension - Oral | 96 MG / ML | 12/31/1993 |
| RIOPAN PLUS SUS | wyeth-ayerst canada inc. | 02043572 | Suspension - Oral | 480 MG / 5 ML | 12/31/1994 |
| RIOPAN SUS 480MG/5ML | whitehall-robins inc. | 01931067 | Suspension - Oral | 480 MG / 5 ML | 12/31/1993 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| BEMOLAN 2000 mg GEL ORAL | Takeda Farmaceutica Espana S.A. | 60765 | GEL ORAL | Sin Receta | Commercialized |
| BEMOLAN 800 mg GEL ORAL | Takeda Farmaceutica Espana S.A. | 57295 | GEL ORAL | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.